Navigation Links
Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
Date:12/13/2012

INDIANAPOLIS, Dec. 13, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will stop one of three Phase 3 rheumatoid arthritis (RA) registration studies of tabalumab, an anti-BAFF monoclonal antibody, due to insufficient efficacy. The decision followed a planned interim futility analysis of the FLEX-M study investigating tabalumab, also known as LY2127399, for the treatment of patients with moderate-to-severe RA who had an inadequate response to methotrexate therapy. The decision was not based on safety concerns, and patients currently enrolled in other tabalumab RA studies will continue treatment.

The FLEX-M study was designed to support registration of tabalumab as a potential treatment for RA, including an assessment of its effect on structural progression. Lilly continues to evaluate tabalumab in two other Phase 3 RA registration studies as well as an open-label extension study and several other smaller studies. Lilly is suspending enrollment of new patients in the RA program until additional analysis from other ongoing RA studies is completed in early 2013. These other studies are in different patient populations.

Phase 3 studies for systemic lupus erythematosus are ongoing and will continue to enroll new patients. Currently, there is no evidence to suggest that efficacy results from the FLEX-M study in RA are indicative of potential efficacy in the lupus population. Lilly remains committed to the ongoing Phase 3 lupus program.

"The results of this study were unexpected given the data generated in earlier Phase II clinical studies of tabalumab," said Eiry Roberts, M.D., vice president of autoimmune product development at Lilly. "We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development program. Beyond tabalumab,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Provides Update on Next Steps for Solanezumab
2. Lilly to Expand Indianapolis Insulin Manufacturing Operations
3. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
4. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
5. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
6. Lilly Announces Results From Lung Cancer Study
7. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
8. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
9. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
10. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
11. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  Dynatronics Corporation ... will present at the First Annual Ladenburg Thalmann ... York City.  Kelvyn H. Cullimore, Jr. , ... leading institutional investment representatives on Tuesday, September 29 ... Ladenburg Thalmann Conference will showcase leading-edge companies in ...
(Date:9/1/2015)... 2015 Sleep Specialists, LLC a medical ... Health Care Solutions, a leader in digital health ... sleep management and cost reduction program for patients ... is a chronic medical condition characterized by periods ... a patient,s risk for cardiovascular disease, hypertension, stroke, ...
(Date:9/1/2015)... , Sept. 1, 2015 Taiwan,s ... a press conference in Taipei ... its new Vaucarrin™ platform, a targeted drug delivery technology ... This event was part of a joint press ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest edible gold-based ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5
... 1, 2011 MMRGlobal, Inc. (OTCBB: MMRF) ... ) have entered into an agreement to ... IT products and services, including MMRPro for healthcare professionals ... Record (PHR) ( www.mmrvideos.com ), on the Visi™ ...
... 31, 2011 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Officer of Neurocrine Biosciences, will be presenting at the Jefferies ... The live presentation takes place on Tuesday, June 7, ... Time.  The presentation will be webcast and may be accessed ...
Cached Medicine Technology:VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia 2VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia 3VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia 4VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia 5
(Date:9/1/2015)... Minnesota (PRWEB) , ... September 01, 2015 , ... ... health care delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) ... in 2016. , Based in San Francisco, Doctor On Demand provides immediate ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Vendor “Hair Extension Vending Machine,” is still strongly maintaining her firm’s success in ... and beauty tools. In her upcoming city-to-city tour, Ellis will be providing “Look ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... Professional Background Screeners (NAPBS®) has announced that Edge Information Management has ... by the Background Screening Credentialing Council (BSCC). , “Achieving and maintaining ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its ... disciplines since its inception more than 35 years ago. A pilot program begun by ... teachers - and, not just those intent on pursuing careers in these fields. The ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Royal River ... new study that followed men and women for 19 years and found that, among ... did not take multivitamins. , The report is part of the September 2015 issue ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... Board Members, Appoints New CEO -, BALTIMORE, ... improving the healthcare of chronically ill seniors, today,announced ... directors to the company,s nine-person board. The modified ... chief executive officer and,chairman of the board., ...
... WINSTON-SALEM, N.C., Jan. 28 DrScore.com, an online,service that lets ... first annual Report Card on Patient Satisfaction in the,U.S., ... company,s,Web site. A few highlights from the report are as ... doctors and their practices across the ...
... microRNAs short strands of RNA that can interfere ... becomes how closely they are associated with cancer. In ... their colleagues have identified two microRNAs (miRNAs) that promote ... may provide an early warning of metastatic breast cancer ...
... Alt receives $1,000 grant for Suicide Awareness Voices ... Alt, a retired,employee with Cargill, earned the company,s ... his work as a volunteer with Suicide,Awareness Voices ... in,Minnesota. Each year the Cargill Cares Volunteer Awards ...
... known if findings apply to humans , , MONDAY, Jan. 28 ... allergic asthma, a new study found. , The mice that ... allergen "inherited" the allergen and developed tolerance to it. , ... animal study can be extrapolated to humans. , "You ...
... PROVIDENCE, R.I. Kids who have been arrested and are ... engage in unsafe sexual activity that puts them at greater ... Hasbro Childrens Research Center. , Findings of the study, published ... Alcohol and Drugs, suggest the need for depression screenings as ...
Cached Medicine News:Health News:XLHealth Corporation Announces Executive Changes 2Health News:DrScore.com Releases Annual Report Card on Patient Satisfaction in the U.S. 2Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3Health News:Volunteer for National Suicide Prevention Agency Earns Cargill Award 2Health News:Breast-Feeding Protected Mice From Asthma 2Health News:Breast-Feeding Protected Mice From Asthma 3Health News:Mental health screenings, risk behavior interventions needed in juvenile justice system 2
... Kit Nebulizer Small Volume Medication Mouthpiece 7FT ... ,These Sidestream® nebulizers are designed ... for any nebulizer treatment with a fast treatment ... with 7` (84") tubing and a vent seal ...
Nebulizer Adapter Kit 6"...
... in Anesthesia and Respiratory Products, ,Westmed ... devices for Anesthesia and Respiratory professionals. Our ... that enhance the clinician's ability to deliver ... to the bottom line. , ,Our ...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
Medicine Products: